Last reviewed · How we verify
NCT04300257
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
trial in Sarcoma in 600 participants. Currently enrolling.
31 December 2029
Quick facts
| Lead sponsor | Kantonsspital Winterthur KSW |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 19 October 2019 |
| Primary completion | 31 December 2029 |
| Estimated completion | 31 December 2029 |
| Sites | 8 locations across Switzerland |
Conditions studied
- Sarcoma — all drugs for Sarcoma →
Sponsor
Kantonsspital Winterthur KSW — full company profile →
Who can join
Eligibility, any sex, with Sarcoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary significance of this project is to perform a detailed analysis to assess the diagnostics, treatment and follow-up care, to develop a prediction model for future patient selection regarding various diagnostic and treatment procedures.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Unlocking the Power of Benchmarking: Real-World-Time Data Analysis for Enhanced Sarcoma Patient Outcomes.
Fuchs B, Schelling G, Elyes M, Studer G, et al · · 2023 · cited 14× · PMID 37686671 · DOI 10.3390/cancers15174395 -
Benchmarking Time-to-Treatment Initiation in Sarcoma Care Using Real-World-Time Data.
Schärer M, Heesen P, Bode-Lesniewska B, Studer G, et al · · 2023 · cited 9× · PMID 38136394 · DOI 10.3390/cancers15245849 -
Enhancing Healthcare for Sarcoma Patients: Lessons from a Diagnostic Pathway Efficiency Analysis.
Elyes M, Heesen P, Schelling G, Bode-Lesniewska B, et al · · 2023 · cited 9× · PMID 37835586 · DOI 10.3390/cancers15194892 -
The Sarcoma-Specific Instrument to Longitudinally Assess Health-Related Outcomes of the Routine Care Cycle.
Mosku N, Heesen P, Christen S, Scaglioni MF, et al · · 2023 · cited 7× · PMID 36980513 · DOI 10.3390/diagnostics13061206 -
Time and Accuracy to Establish the Diagnosis of Soft Tissue Tumors: A Comparative Analysis from the Swiss Sarcoma Network.
Wellauer H, Studer G, Bode-Lesniewska B, Fuchs B. · · 2022 · cited 6× · PMID 35535046 · DOI 10.1155/2022/7949549 -
Planned and Unplanned Sarcoma Resections: Comparative Analysis of Local Recurrence, Metastasis, and Mortality.
Nydegger KN, Obergfell TTAF, Heesen P, Schelling G, et al · · 2024 · cited 5× · PMID 39410028 · DOI 10.3390/cancers16193408 -
Improving Sarcoma Outcomes: Target Trial Emulation to Compare the Impact of Unplanned and Planned Resections on the Outcome.
Obergfell TTAF, Nydegger KN, Heesen P, Schelling G, et al · · 2024 · cited 5× · PMID 39001505 · DOI 10.3390/cancers16132443 -
From Data Integration to Precision Medicine: A Value-Based Healthcare Approach for Sarcoma Care.
Fuchs B, Heesen P, SwissSarcomaNetwork. · · 2024 · cited 4× · PMID 39518639 · DOI 10.3390/jcm13216500
Verify or expand the search:
- PubMed search for NCT04300257
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sarcoma
Currently open trials in the same condition.
- NCT07402577 — Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot · recruiting
- NCT07501026 — Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC) · Phase 2 · recruiting
- NCT07359911 — Effect of A Multimodal Exercise Intervention on Chemotherapy Uptake in Newly Diagnosed Pediatric and AYA Sarcoma Patient · NA · recruiting
- NCT07410676 — EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
- NCT07222735 — Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcoma · Phase 1 · recruiting
Other Kantonsspital Winterthur KSW trials
Trials by the same sponsor.
- NCT06864117 — Urodynamics: Prone Vs. Seated Position · NA · not yet recruiting
- NCT06384053 — Skin Cancer and Hyperthermia and Radiotherapy · NA · recruiting
- NCT06272513 — Influencing Factors for Physical Activity in People With Head and Neck Cancer · completed
- NCT06135402 — Comparison of Laser Treatment With Clobetasol Therapy in Patients With Lichen Sclerosus · NA · recruiting
- NCT06643325 — Gastric Emptying Time in Traumatic Injuries · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04300257 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kantonsspital Winterthur KSW
- Last refreshed: 20 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04300257.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing